Read more on our Global Newsroom. The global mergers and acquisitions (M&A) market remained strong during the first half of 2017, despite rising protectionist sentiment and increasing intervention in deals by governments and regulators. The outlook for the remainder of the year and beyond is positive, particularly with private equity (PE) investors returning to the … More New deal terrain is no barrier for traditional players as global M&A activity remains strong
Originally published on betterworkingworld.ey.com. EY, Unilever and The B Team explore why organizations must be more human if they are to deliver sustained growth in a connected world. We are living in an increasingly fragmented world with a crisis of slowing growth in many developed economies. Meanwhile, many brands and employers are attempting to become … More In a digital world, how can being more human be key to unlocking more growth?
It was supposed to be a bad year for biotech. For this sector, the simplest of truisms has always held: what goes up must eventually come down. Markets peaked in 2015 and declined in 2016; payer pressure and US election year rhetoric weighed on the sector; drug approvals fell sharply; and biotech companies faced a … More Beyond borders: Biotechnology report 2017 – Staying the course
Despite current geopolitical and financial market volatility, investment plans into Europe over the next three years are strong, with 56% of global investors planning to grow their presence in Europe, according to the EY 2017 European attractiveness survey – Plan B for Brexit. This contrasts with the findings from the EY survey conducted last May, … More Strong global investment appetite into Europe despite geopolitical instability
In a much anticipated speech on 17 January 2017, the Prime Minister, Mrs. May, announced the UK’s 12 priorities for Brexit negotiations. The resolution of the tension between maintaining access to the single market and controlling immigration had been a key unresolved political issue, as had the continuing membership of the Customs Union. The Prime … More UK Prime Minister outlines position in Brexit negotiations
The historic decision by the voters of the UK to leave the EU marks a significant change for the UK and EU and will impact other trading partners such as the US. However, all EU directives and regulations, as well as the treaties themselves, remain in force in respect of the UK until it formally … More Navigating Brexit: Tax and legal implications for life sciences
The potential legal issues raised by the departure of the UK from the European Union (EU) are unprecedented. However, one thing is clear – until the exit, in terms of the content and stability of UK law, nothing will change. The UK remains bound by its EU Treaty obligations and directly applicable EU law will … More The UK votes to leave the EU: initial legal observations
Amid ongoing economic and political uncertainty, the global IPO market will continue to be a stop-start affair in 2016. However, greater clarity regarding the economic and political landscape will emerge by the end of the year, allowing companies to reinvigorate their IPO strategies, while the recent growth in the availability of private capital will continue … More Delayed but not derailed: global IPO market looks ahead to 2017